Chronic Myeloproliferative Disorders Clinical Trials

• Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Chronic Idiopathic Myelofibrosis or Myelodysplastic or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00274820 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00293410 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases
  
• Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00433862 - Recruiting
  Polycythemia Vera; Essential Thrombocytosis; Idiopathic Myelofibrosis; Neutrophils; Chronic Myeloproliferative Disorders
  
• Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00437086 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia
  
• Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00005622 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00381550 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia
  
• Fludarabine and Total-Body Irradiation Followed By a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00397813 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis
  
• Donor Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome and Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00052546 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00005797 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00253552 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Sarcoma
  
• Donor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00049634 - Recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00357305 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
  ClinicalTrials.gov Identifier: NCT00544115 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
  
• Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00066300 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00530218 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Filgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00075816 - Recruiting
  acute leukemia; chronic leukemia; chronic myeloproliferative disorders; myelodysplastic and myeloproliferative disease
  
• Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
  ClinicalTrials.gov Identifier: NCT00066417 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases
  
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00068523 - Active, not recruiting
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00054340 - Active, not recruiting
  acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Chemotherapy, Stem Cell Transplantation, and Graft-Versus-Host-Disease Prevention in Treating Patients With Refractory or Relapsed Hematologic Cancer, Myelodysplastic Syndrome, or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00055744 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00351975 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00104923 - Recruiting
  Hodgkin's lymphoma; acute leukemia; chronic leukemia; chronic myeloproliferative disorders; Non-Hodgkin's Lymphoma; plasma cell neoplasm
  
• A Safety Study of XL019 in Adults With Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00522574 - Recruiting
  Myeloproliferative Disorders; Myelofibrosis; Polycythemia Vera; Thrombocythemia, Essential
  
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00290628 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00357708 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00227591 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00245128 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00376922 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Pain; Psychosocial Effects/Treatment
  
• Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00281814 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Psychosocial Effects/Treatment
  
• Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00281775 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00295997 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301912 - Recruiting
  Anemia; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00245037 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00305682 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Zoledronate in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00321932 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Osteoporosis; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00064311 - Active, not recruiting
  Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00281801 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Psychosocial Effects/Treatment; Quality of Life
  
• Sunitinib in Treating Patients With Idiopathic Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00387426 - Recruiting
  Chronic Myeloproliferative Disorders
  
• Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00499668 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific
  
• Azacitidine in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00381693 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00281879 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unusual Cancers of Childhood
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00255684 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Clofarabine, Melphalan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00572546 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition; Secondary Myelofibrosis
  
• T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00080925 - Recruiting
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00186342 - Active, not recruiting
  Myeloproliferative Disorders; Acute Disease; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
  
• Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00186576 - Active, not recruiting
  Myeloproliferative Disorders; Myelodysplastic Syndromes
  
• Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00445900 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
  ClinicalTrials.gov Identifier: NCT00004058 - Completed
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00077480 - Recruiting
  chronic myeloproliferative disorders; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00053989 - Recruiting
  childhood Hodgkin's lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Pegasys® in Patients With Myeloproliferative Diseases
  ClinicalTrials.gov Identifier: NCT00452023 - Recruiting
  Myeloproliferative Disorders
  
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00398346 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis; Small Intestine Cancer
  
• Fludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Peripheral Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00268268 - Recruiting
  Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
  
• 3-AP and Cytarabine in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00064090 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease
  
• Beclomethasone in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00489203 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Investigation of the Cylex® ImmuKnow® Assay
  ClinicalTrials.gov Identifier: NCT00569842 - Recruiting
  Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Hodgkin's Disease; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Aplastic Anemia; Chronic Myelogenous Leukemia
  
• Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00410657 - Active, not recruiting
  Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Tipifarnib in Treating Patients With Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00005846 - Completed
  atypical chronic myeloid leukemia; Chronic Myelogenous Leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease
  
• Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003838 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; ...
  
• Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00445952 - Recruiting
  Breast Cancer; Chronic Myeloproliferative Disorders; Colorectal Cancer; Infection; Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unspecified Adult Solid Tumor, Protocol Specific
  
• Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00296023 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00324324 - Recruiting
  Brain and Central Nervous System Tumors; Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Combination Chemotherapy and Radiation Therapy Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00303719 - Recruiting
  Breast Cancer; Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Experimental Bone Marrow Transplant Protocol
  ClinicalTrials.gov Identifier: NCT00061581 - No longer recruiting
  Acute Lymphocytic Leukemia; Chronic Myeloid Leukemia; Acute Myelocytic Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders
  
• Peritransplant Cyclosporine in Treating Patients With Hematologic Malignancies Undergoing T-Cell Depleted Allogeneic Stem Cell Transplant Followed By T-Cell Add-Back
  ClinicalTrials.gov Identifier: NCT00079391 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disease
  ClinicalTrials.gov Identifier: NCT00114257 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; chronic myeloproliferative disorders; Leukemia; ...
  
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
  ClinicalTrials.gov Identifier: NCT00255346 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes; Agnogenic Myeloid Metaplasia; Myelofibrosis; Hypereosinophilic Syndrome; Polycythemia Vera; Mastocytosis; Leukemia, Myelomonocytic, Chronic
  
• Cyclophosphamide and Busulfan Followed By Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00445744 - Recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• Sirolimus to Prevent GVHD after Stem Cell Transplant for Blood Cancers
  ClinicalTrials.gov Identifier: NCT00074490 - Recruiting
  Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders
  
• VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00083187 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00295880 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00134004 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
  
• Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00104975 - Completed
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00049686 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Hairy Cell Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Aprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00293384 - Recruiting
  Brain and Central Nervous System Tumors; Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nausea and Vomiting; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00134017 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
  
• Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002746 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00043134 - Recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00020969 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00453206 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00513474 - Not yet recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
  ClinicalTrials.gov Identifier: NCT00511537 - Recruiting
  CML; ALL; AML; Myelodysplasia; Lymphoma; Myeloproliferative Disorders
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00309842 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Low-Intensity Preparation and Allogeneic Transplant in Patients with Cancers of the Blood
  ClinicalTrials.gov Identifier: NCT00146055 - Active, not recruiting
  Myeloma, Plasma-Cell; Lymphoma, Malignant; Myeloproliferative Disorders; Myelodysplastic Syndromes; Waldenstrom''s Macroglobulinemia
  
• Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00448201 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00448357 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00104806 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00047268 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
  ClinicalTrials.gov Identifier: NCT00276926 - Recruiting
  Hypereosinophilic Syndrome; Chronic Eosinophilic Leukemia (CEL); Myeloproliferative Disorders
  
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00014469 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00003336 - Active, not recruiting
  atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Safety and Efficacy of Hum195/rGel in Patients with Advanced Myeloid Malignancies
  ClinicalTrials.gov Identifier: NCT00038051 - Recruiting
  Myelodysplastic Syndromes; Leukemia, Myelocytic, Acute; Anemia, Refractory, with Excess of Blasts; Myeloproliferative Disorders
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Umbilical Cord Blood Stem Cell Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer and Other Diseases
  ClinicalTrials.gov Identifier: NCT00343798 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
  ClinicalTrials.gov Identifier: NCT00424242 - Recruiting
  Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Secondary Myelofibrosis; Unspecified Adult Solid Tumor, Protocol Specific
  
• Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00438958 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Secondary Myelofibrosis
  
• Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00255710 - Completed
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• A Safety Study of SGN-33 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00283114 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic
  
• Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00346359 - Suspended
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00072475 - Recruiting
  Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
  ClinicalTrials.gov Identifier: NCT00516152 - Recruiting
  Chronic Myeloid Leukemia; Acute Myelogenous Leukemia; Myelodysplasia; Acute Lymphocytic Leukemia; Severe Aplastic Anemia; Non-Hodgkin's Lymphoma; Lymphoproliferative Disease; Multiple Myeloma; Advanced Myeloproliferative Disease